Literature DB >> 6367634

Kinetic studies on the inhibition of Proteus vulgaris beta-lactamase by imipenem.

T Hashizume, A Yamaguchi, T Hirata, T Sawai.   

Abstract

Imipenem was found to inhibit Proteus vulgaris beta-lactamase in a progressive manner. Kinetic experiments confirmed that the inactivated enzyme was not completely recovered after intact imipenem had been exhausted.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6367634      PMCID： PMC185458          DOI： 10.1128/AAC.25.1.149

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  16 in total

1.  A set of bacterial strains for evaluation of beta-lactamase-stability of beta-lactam antibiotics.

Authors:  T Sawai; T Yoshida; K Tsukamoto; S Yamagishi
Journal:  J Antibiot (Tokyo)       Date:  1981-10       Impact factor: 2.649

2.  The semi-synthetic thienamycin derivative MK0787 and its properties with respect to a range of beta-lactamases from clinically relevant bacterial species.

Authors:  M H RIchmond
Journal:  J Antimicrob Chemother       Date:  1981-03       Impact factor: 5.790

3.  PS-5 inhibition of a beta-lactamase from Proteus vulgaris.

Authors:  K Okamura; M Sakamoto; T Ishikura
Journal:  J Antibiot (Tokyo)       Date:  1980-03       Impact factor: 2.649

4.  Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of the enzyme with derivatives of olivanic acid.

Authors:  C J Easton; J R Knowles
Journal:  Biochemistry       Date:  1982-06-08       Impact factor: 3.162

5.  Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  J Fisher; R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

6.  Chemical studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  R L Charnas; J Fisher; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

7.  Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Authors:  J S Kahan; F M Kahan; R Goegelman; S A Currie; M Jackson; E O Stapley; T W Miller; A K Miller; D Hendlin; S Mochales; S Hernandez; H B Woodruff; J Birnbaum
Journal:  J Antibiot (Tokyo)       Date:  1979-01       Impact factor: 2.649

8.  [Kinetics of beta-lactamase inhibition by clavulanic acid].

Authors:  R Labia; J Peduzzi
Journal:  Biochim Biophys Acta       Date:  1978-10-12

9.  Inhibition of the RTEM beta-lactamase from Escherichia coli. Interaction of enzyme with derivatives of olivanic acid.

Authors:  R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1981-05-12       Impact factor: 3.162

10.  Penicillanic acid sulfone: an unexpected isotope effect in the interaction of 6 alpha- and 6 beta-monodeuterio and of 6,6-dideuterio derivatives with RTEM beta-lactamase from Escherichia coli.

Authors:  D G Brenner; J R Knowles
Journal:  Biochemistry       Date:  1981-06-23       Impact factor: 3.162
View more
  7 in total

1.  IBC-1, a novel integron-associated class A beta-lactamase with extended-spectrum properties produced by an Enterobacter cloacae clinical strain.

Authors:  P Giakkoupi; L S Tzouvelekis; A Tsakris; V Loukova; D Sofianou; E Tzelepi
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 2.  Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.

Authors:  D M Livermore
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

3.  Chromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganii.

Authors:  Y J Yang; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

4.  Imipenem as substrate and inhibitor of beta-lactamases.

Authors:  J Monks; S G Waley
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

Review 5.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

6.  Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.

Authors:  A Raimondi; A Traverso; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

Review 7.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.